Skip to main content
Premium Trial:

Request an Annual Quote

Change is Good?


Usually citing a need for a moniker that better describes their mission, companies in the genomics sector seem to come up with new names as often as DNA replicates itself. Here we’ve listed 20 companies or organizations that either changed their name or merged under a new one in the years since GT has been covering this sector. See if you can match each new company name in the right column with its former self in the left column. Think the new name makes the corporate agenda any more obvious?


Find the answers at





1. AniGenics

2. Applied Metacomputing

3. BASF-Lynx

4. Edinburgh Biocomputing Systems

5. eDNA

6. GeneSys Technologies

7. GenMatics

8. LabBook

9. Myriad Proteomics

10. PPGx, then DNA Sciences Laboratories

11. Ribozyme Pharmaceuticals

12. Secant Technologies

13. Soane BioSciences

14. TurboGenomics

15. Incyte Genomics

16. Indiana Proteomics Consortium

17. Blackstone Technologies and Blackstone Computing

18. GeneFormatics and Structural Bioinformatics

19. Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and Genetics Computer Group

20. Variagenics and Hyseq

21. Pyrosequencing




A. ProSanos

B. Axaron Bioscience

C. Prolexys

D. TurboWorx

E. Rescentris

F. Avaki

G. Incyte

H. Accelrys

J. Waban Software

K. InProteo

L. Acero

M. Biotage

N. MJ Bioworks

O. OpGen

P. Argentys

Q. Sirna

R. Aneda

S Pyxis Genomics

T. Cengent Therapeutics

U. Nuvelo

V. Aclara


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.